These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5841666)

  • 1. [Tolazamide and hepatic damage].
    Ferrero E; Marioni G; Antognetti R; Falchi F
    Minerva Med; 1965 Oct; 56(85):3609-13. PubMed ID: 5841666
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolazamide in the treatment of diabetes mellitus.
    Baird IM; Evans JH; Hirst J; Longson D
    Practitioner; 1967 Feb; 198(184):264-7. PubMed ID: 6038982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoglycemia caused by oral antidiabetic agents].
    de Baere H; Decraene P; de Leeuw I; Lemmens P; Verhaegen H
    Ned Tijdschr Geneeskd; 1973 Jul; 117(27):1021-4. PubMed ID: 4206176
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 2 diabetes therapy and liver damage: the debate continues.
    Zangeneh F; Basu A
    Postgrad Med; 2002 Sep; 112(3):23; author reply 23-4, 82. PubMed ID: 12360654
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged and recurrent tolazamide-induced hypoglycemia. Report of a case.
    Rull JA; Lennhoff M
    Diabetes; 1967 May; 16(5):352-3. PubMed ID: 6022563
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of chronic liver disease due to tolazamide.
    Nakao NL; Gelb AM; Stenger RJ; Siegel JH
    Gastroenterology; 1985 Jul; 89(1):192-5. PubMed ID: 4007403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolazamide-induced cholestasis.
    Bridges ME; Pittman FE
    South Med J; 1980 Aug; 73(8):1072-4. PubMed ID: 7403921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolazamide hepatotoxicity. A case report.
    Van Thiel DH; De Belle R; Mellow M; Widerlite L; Philipps E
    Gastroenterology; 1974 Sep; 67(3):506-10. PubMed ID: 4855219
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolazamide-induced hepatic dysfunction.
    LoIudice TA; Lang JA
    Am J Gastroenterol; 1978 Jan; 69(1):81-3. PubMed ID: 645691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolazamide in the control of diabetes mellitus].
    Ramos JV
    Prensa Med Mex; 1969; 34(1):66-7. PubMed ID: 5787505
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial with tolazamide, a new hypoglycemia agent; its potency compared to chlorpropamide.
    Quismorio FT; Villadolid LS; Egay LM; Wico AR; Llamas SP; Acurantes AI
    Acta Med Philipp; 1967; 3(4):261-5. PubMed ID: 6069635
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver failure in a patient receiving rosiglitazone therapy.
    Su DH; Lai MY; Wu HP
    Diabet Med; 2006 Jan; 23(1):105-6. PubMed ID: 16409577
    [No Abstract]   [Full Text] [Related]  

  • 13. Pioglitazone-associated fulminant hepatic failure.
    Chase MP; Yarze JC
    Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of tolazamide on serum cholesterol].
    López Amor E; Lozano Castañeda O; Domenque L
    Rev Invest Clin; 1966; 18(2):229-37. PubMed ID: 5973929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with tolazamide].
    Laffi GC; Bruno GM
    Minerva Med; 1965 Sep; 56(75):3213-5. PubMed ID: 5320010
    [No Abstract]   [Full Text] [Related]  

  • 16. Miglitol and hepatotoxicity in type 2 diabetes mellitus.
    Carlson RF
    Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver function during long-term administration of oral antidiabetic drugs].
    Skrha F; Josífko M
    Vnitr Lek; 1976 Jun; 22(6):554-8. PubMed ID: 936498
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolazamide (Tolinase).
    Clin Pharmacol Ther; 1969; 10(3):423-7. PubMed ID: 5815951
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical behavior of some hepatic and renal function tests in subjects with pulmonary tuberculosis treated with 2,2'(ethylenediimino) di-1-butanol].
    Ramacciotti PG; Lijoi N; Busin M
    G Ital Chemioter; 1966; 13(1):139-47. PubMed ID: 5995798
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acarbose can have adverse effects on the liver].
    Lakartidningen; 1997 Feb; 94(8):655-6. PubMed ID: 9072658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.